Lung Cancer Survival Data May Help Merck’s Keytruda Catch Up
This article was originally published in The Pink Sheet Daily
Executive Summary
Top-line data from KEYNOTE-010 suggest opportunity for Keytruda to broaden its reach to a wider population with lower expression of the PD-L1 biomarker.